Some studies have demonstrated the oncogenic potential of the STK38 gene in progressive ductal carcinoma in situ in the breast tissue [15], lung adenocarcinoma [16,17] and ovarian cancer [18]. This evidence concerns the gene STK38 and lung adenocarcinoma.